NCT05591937 S.T.A.N.D. Alacrity Center Signature Project
| NCT ID | NCT05591937 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2022-08-29 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2022-08-29 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate clinical decision-making algorithms for (a) triaging to level of care and (b) adapting level of care in a low income, highly diverse sample of community college students at East Los Angeles College (ELAC). The target enrollment is 200 participants per year, for five years (N=1000). Participants are between the ages of 18 and 40 years and will be randomized into either symptom severity decision-making (SSD) or data-driven decision-making (DDD). Participants in each condition will be triaged to one of three levels of care, including self-guided online prevention, coach-guided online cognitive behavioral therapy, and clinician-delivered care. After initial triaging, level of care will be adapted throughout the entire time of the study enrollment. Participants will complete computerized assessments and self-report questionnaires as part of the study. The total length of participation is 40 weeks.
Eligibility Criteria
Inclusion Criteria: * Currently enrolled in the East Los Angeles College * Either uninsured or covered by California Medicaid * Own or have private access to internet to complete the assessments and online prevention and therapy programs Exclusion Criteria: * Unable to fully comprehend the consent form, respond adequately to screening questions, or maintain focus or to sit still during assessment * Diagnosed with disorders requiring more specialized care (e.g., psychotic disorder, severe eating disorder, severe substance use disorder, severe neurological disorder), or marked cognitive impairment * Currently treated by psychiatrist or psychologist during timeframe that the treatment is offered through STAND and is unwilling to fully transfer care to STAND
Contact & Investigator
Michelle Craske, Ph.D
PRINCIPAL INVESTIGATOR
University of California, Los Angeles
Frequently Asked Questions
Who can join the NCT05591937 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05591937 currently recruiting?
Yes, NCT05591937 is actively recruiting participants. Contact the research team at awelborn@mednet.ucla.edu for enrollment information.
Where is the NCT05591937 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT05591937 clinical trial?
NCT05591937 is sponsored by University of California, Los Angeles. The principal investigator is Michelle Craske, Ph.D at University of California, Los Angeles. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.